Revolutionary New Technology

Neuraptive is bringing the world's first truly therapeutic solution for the repair of cut and crushed peripheral nerves. Based on extensive preclinical and early clinical testing, this technology has the potential to advance the recovery cycle and improve the final outcome dramatically.

DISCOVER HOW

Recent News

Aug 21, 2017

Neuraptive Therapeutics, Inc., a Colorado-based biotech startup, raised $1 million in a seed funding round led by the Central Texas Angel Network, with participation from New Rhein Healthcare Investors LLC and several angel investors.

READ MORE
Aug 18, 2017

Core Technology Secured: Neuraptive exercises option to PEG-fusion technology from UT

Aug 17, 2017

Initial Financing: Neuraptive secures initial round of financing led by the Central Texas Angel Network

May 10, 2017

Core Technology Optioned: Neuraptive optioned PEG-fusion technology from University of Texas

THE AXOFUSE® SYSTEM

The AxoFuse® System is the first therapeutic technology that can truly solve nerve injuries

LEARN ABOUT AXOFUSE

NEURAPTIVE'S PARTNERS